Department of Pharmacology, University of Illinois, Chicago, Illinois.
The Affiliated Hospital of Medical School, Ningbo University, Ningbo, China.
J Biol Chem. 2020 May 29;295(22):7669-7685. doi: 10.1074/jbc.RA119.011801. Epub 2020 Apr 23.
Increased permeability of vascular lung tissues is a hallmark of acute lung injury and is often caused by edemagenic insults resulting in inflammation. Vascular endothelial (VE)-cadherin undergoes internalization in response to inflammatory stimuli and is recycled at cell adhesion junctions during endothelial barrier re-establishment. Here, we hypothesized that phospholipase D (PLD)-generated phosphatidic acid (PA) signaling regulates VE-cadherin recycling and promotes endothelial barrier recovery by dephosphorylating VE-cadherin. Genetic deletion of impaired recovery from protease-activated receptor-1-activating peptide (PAR-1-AP)-induced lung vascular permeability and potentiated inflammation In human lung microvascular endothelial cells (HLMVECs), inhibition or deletion of PLD2, but not of PLD1, delayed endothelial barrier recovery after thrombin stimulation. Thrombin stimulation of HLMVECs increased co-localization of PLD2-generated PA and VE-cadherin at cell-cell adhesion junctions. Inhibition of PLD2 activity resulted in prolonged phosphorylation of Tyr-658 in VE-cadherin during the recovery phase 3 h post-thrombin challenge. Immunoprecipitation experiments revealed that after HLMVECs are thrombin stimulated, PLD2, VE-cadherin, and protein-tyrosine phosphatase nonreceptor type 14 (PTPN14), a PLD2-dependent protein-tyrosine phosphatase, strongly associate with each other. PTPN14 depletion delayed VE-cadherin dephosphorylation, reannealing of adherens junctions, and barrier function recovery. PLD2 inhibition attenuated PTPN14 activity and reversed PTPN14-dependent VE-cadherin dephosphorylation after thrombin stimulation. Our findings indicate that PLD2 promotes PTPN14-mediated dephosphorylation of VE-cadherin and that redistribution of VE-cadherin at adherens junctions is essential for recovery of endothelial barrier function after an edemagenic insult.
血管肺组织通透性增加是急性肺损伤的标志,通常由导致炎症的水肿性损伤引起。血管内皮(VE)-钙黏蛋白在内皮屏障重建过程中,对炎症刺激发生内化,并在细胞黏附连接处进行再循环。在这里,我们假设磷脂酶 D(PLD)产生的磷酸脂酸(PA)信号调节 VE-钙黏蛋白的再循环,并通过去磷酸化 VE-钙黏蛋白促进内皮屏障的恢复。蛋白酶激活受体-1 激活肽(PAR-1-AP)诱导的肺血管通透性增加和炎症增强,敲除 会损害肺血管通透性的恢复。在人肺微血管内皮细胞(HLMVECs)中,抑制或敲除 PLD2,但不抑制 PLD1,会延迟凝血酶刺激后的内皮屏障恢复。凝血酶刺激 HLMVECs 会增加 PLD2 生成的 PA 和 VE-钙黏蛋白在细胞-细胞黏附连接处的共定位。PLD2 活性抑制会导致在凝血酶刺激后 3 小时的恢复阶段 VE-钙黏蛋白的 Tyr-658 持续磷酸化。免疫沉淀实验表明,在 HLMVECs 受到凝血酶刺激后,PLD2、VE-钙黏蛋白和蛋白酪氨酸磷酸酶非受体型 14(PTPN14),一种 PLD2 依赖性蛋白酪氨酸磷酸酶,彼此强烈结合。PTPN14 耗竭会延迟 VE-钙黏蛋白去磷酸化、黏附连接的重新连接和屏障功能的恢复。PLD2 抑制会减弱 PTPN14 的活性,并在凝血酶刺激后逆转 PTPN14 依赖性 VE-钙黏蛋白去磷酸化。我们的研究结果表明,PLD2 促进 PTPN14 介导的 VE-钙黏蛋白去磷酸化,VE-钙黏蛋白在黏附连接处的重新分布对于水肿性损伤后内皮屏障功能的恢复至关重要。